Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naridrin vs Afrin for Pediatric Nasal Congestion
NCT02601235Phase 3Completed
- Sponsor
- EMS
- Start
- Jan 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of naridrin in nasal congestion (2 arms), sponsored by EMS. Primary endpoint: Relief of Nasal Congestion at 2 days. Started Jan 2018; status: completed.
02
Drugs
naridrin
03
Conditions
nasal congestion
Beyond the preview
Go deeper on NCT02601235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601235.